Current progress in stem cell therapy for type 1 diabetes mellitus
Abstract Type 1 diabetes mellitus (T1DM) is the most common chronic autoimmune disease in young patients and is characterized by the loss of pancreatic β cells; as a result, the body becomes insulin deficient and hyperglycemic. Administration or injection of exogenous insulin cannot mimic the endoge...
Main Authors: | Shuai Chen, Kechen Du, Chunlin Zou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-020-01793-6 |
Similar Items
-
Mesenchymal Stem Cells: A Trump Card for the Treatment of Diabetes?
by: Elisabetta Donzelli, et al.
Published: (2020-05-01) -
Regenerative and Transplantation Medicine: Cellular Therapy Using Adipose Tissue-Derived Mesenchymal Stromal Cells for Type 1 Diabetes Mellitus
by: Hiroyuki Takahashi, et al.
Published: (2019-02-01) -
Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control
by: Min Jung Kim, et al.
Published: (2020-10-01) -
Adipose stem cells from chronic pancreatitis patients improve mouse and human islet survival and function
by: Lili Song, et al.
Published: (2017-08-01) -
Differential Function and Maturation of Human Stem Cell-Derived Islets After Transplantation
by: Gale, S.E, et al.
Published: (2022)